Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Wada

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|January 24, 2009
Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicityShohei Domae, Yoichi Nakamura, Yurika Nakamura, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2025
Bacteria-derived DNA in serum extracellular vesicles as a biomarker for gastric cancerKaoru Fujikawa, Takuro Saito, Atsunari Kawashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular CarcinomaTameyoshi Yamamoto, Hiroaki Nagano, Masato Sakon, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2023
T cell immunity in interstitial lung disease with non-small cell lung cancer patientsTomomi Isono, Kota Iwahori, Masahiro Yanagawa, et al.
International Immunology|February 4, 2020
PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancerMasaaki Sawada, Kumiko Goto, Akiko Morimoto-Okazawa, et al.
Scientific Reports|October 19, 2022
Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patientsKota Iwahori, Takeshi Uenami, Yukihiro Yano, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 2022
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancerYohei Nose, Takuro Saito, Kei Yamamoto, et al.
Heliyon|October 9, 2023
Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinomaToshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi, et al.
International Journal of Oncology|December 9, 2004
Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy numberShuichiro Sato, Yuji Noguchi, Hisashi Wada, et al.
Cancer Science|August 27, 2025
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL-4, Enhancing Tumor Growth in Hepatocellular CarcinomaDaijiro Matoba, Takehiro Noda, Shogo Kobayashi, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|January 24, 2009
Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicityShohei Domae, Yoichi Nakamura, Yurika Nakamura, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2025
Bacteria-derived DNA in serum extracellular vesicles as a biomarker for gastric cancerKaoru Fujikawa, Takuro Saito, Atsunari Kawashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular CarcinomaTameyoshi Yamamoto, Hiroaki Nagano, Masato Sakon, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2023
T cell immunity in interstitial lung disease with non-small cell lung cancer patientsTomomi Isono, Kota Iwahori, Masahiro Yanagawa, et al.
International Immunology|February 4, 2020
PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancerMasaaki Sawada, Kumiko Goto, Akiko Morimoto-Okazawa, et al.
Scientific Reports|October 19, 2022
Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patientsKota Iwahori, Takeshi Uenami, Yukihiro Yano, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 2022
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancerYohei Nose, Takuro Saito, Kei Yamamoto, et al.
Heliyon|October 9, 2023
Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinomaToshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi, et al.
International Journal of Oncology|December 9, 2004
Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy numberShuichiro Sato, Yuji Noguchi, Hisashi Wada, et al.
Cancer Science|August 27, 2025
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL-4, Enhancing Tumor Growth in Hepatocellular CarcinomaDaijiro Matoba, Takehiro Noda, Shogo Kobayashi, et al.
Pageof 10